Log In
person
Fulgent Genetics Inc
FLGT
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Laboratory services |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
151.95M | 52.54% |
| Laboratory services |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
134.19M | 46.40% |
| Laboratory services |
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
3.08M | 1.06% |
| Therapeutic development |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Laboratory services
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
|
151.95M | 52.54% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||
| keyboard_arrow_down |
Laboratory services
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
|
134.19M | 46.40% |
| keyboard_arrow_right |
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
||
| keyboard_arrow_down |
Laboratory services
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
|
3.08M | 1.06% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||
| keyboard_arrow_down |
Therapeutic development
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||